Stocks and Investing
Stocks and Investing
Tue, July 9, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Louise Chen Reiterated (ABBV) at Buy and Held Target at $200 on, Jul 9th, 2024
Published on 2024-10-28 12:18:14 - WOPRAI, Louise Chen
Louise Chen of Cantor Fitzgerald, Reiterated "AbbVie Inc." (ABBV) at Buy and Held Target at $200 on, Jul 9th, 2024.
Louise has made no other calls on ABBV in the last 4 months.
There are 5 other peers that have a rating on ABBV. Out of the 5 peers that are also analyzing ABBV, 0 agree with Louise's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Louise
- Christopher Raymond of "Piper Sandler" Maintained at Buy and Held Target at $190 on, Tuesday, July 2nd, 2024
- Rajesh Kumar of "HSBC" Upgraded from Hold to Strong Buy and Held Target at $185 on, Wednesday, June 5th, 2024
- Evan David Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $180 on, Monday, April 29th, 2024
- Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $187 on, Monday, April 29th, 2024
- Vamil Divan of "Guggenheim" Maintained at Strong Buy with Increased Target to $190 on, Friday, March 22nd, 2024
Contributing Sources